Skip to main content
. 2017 Aug 24;38(11):1475–1485. doi: 10.1038/aps.2017.116

Figure 6.

Figure 6

LMSCs support the proliferation of K562 cells more than NMSCs. The proliferation of K562 cells treated with the supernatants of NMSCs and LMSCs for 24 h (A) and 48 h (B), respectively, was assessed using the CCK-8 assay (n=3). The detected BCR-ABL1 mRNA of NMSCs and LMSCs (C) and secreted TGF-β1 protein in their supernatants (D) were compared (n=3). LMSCs and BM-MSCs from CML patients and NMSCs and BM-MSCs from patients with benign hematological disease. nsP>0.05; *P<0.05.